Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
Brain Communications
|
December 13, 2024
Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome
Nitin Sahi, Lukas Haider, Karen Chung, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
Francesco Grussu, Torben Schneider, Carmen Tur, et al.
Brain : a Journal of Neurology
|
April 27, 2021
Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event
Sara Collorone, Ferran Prados, Baris Kanber, et al.
Scientific Reports
|
February 27, 2025
Evaluation of magnetic resonance spectroscopy total sodium concentration measures, and associations with microstructure and physical impairment in cervical myelopathy
Bhavana S Solanky, Ferran Prados, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 14, 2017
Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients
Jordi Río, Àlex Rovira, Mar Tintoré, et al.
Frontiers in Neurology
|
December 13, 2021
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
Ratthaporn Boonsuth, Rebecca S Samson, Carmen Tur, et al.
Eclinicalmedicine
|
March 8, 2023
Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational study
Jed Wingrove, Janine Makaronidis, Ferran Prados, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 3, 2012
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision
Carmen Tur, Mar Tintoré, Angela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 11, 2019
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis
Carmen Tur, Francesco Grussu, Ferran Prados, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
Brain Communications
|
December 13, 2024
Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome
Nitin Sahi, Lukas Haider, Karen Chung, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
Francesco Grussu, Torben Schneider, Carmen Tur, et al.
Brain : a Journal of Neurology
|
April 27, 2021
Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event
Sara Collorone, Ferran Prados, Baris Kanber, et al.
Scientific Reports
|
February 27, 2025
Evaluation of magnetic resonance spectroscopy total sodium concentration measures, and associations with microstructure and physical impairment in cervical myelopathy
Bhavana S Solanky, Ferran Prados, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 14, 2017
Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients
Jordi Río, Àlex Rovira, Mar Tintoré, et al.
Frontiers in Neurology
|
December 13, 2021
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
Ratthaporn Boonsuth, Rebecca S Samson, Carmen Tur, et al.
Eclinicalmedicine
|
March 8, 2023
Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational study
Jed Wingrove, Janine Makaronidis, Ferran Prados, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 3, 2012
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision
Carmen Tur, Mar Tintoré, Angela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 11, 2019
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis
Carmen Tur, Francesco Grussu, Ferran Prados, et al.
Page
of 15